NCT04427917View on ClinicalTrials.gov

Study of Multiple Oral Doses of PF-06835919 in Healthy Adult Japanese Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 24, 2020

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
Healthy
Interventions
DRUG

PF-06835919

PF-06835919 300 mg repeated doses

DRUG

Placebo

Placebo repeated doses

Trial Locations (1)

B-1070

Brussels Clinical Research Unit, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04427917 - Study of Multiple Oral Doses of PF-06835919 in Healthy Adult Japanese Participants | Biotech Hunter | Biotech Hunter